GBI Research has released its pharma research, “”Ophthalmology Therapeutics in Major Developed Markets to 2019 New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies””, which provides insights into two therapeutic indications in ophthalmology in […]
November 2013 Life Science Industry Research Reports
Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat
GBI Research has released its pharmaceutical research, “”Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat””, which provides insights into three cardiovascular therapeutic indications in the top eight markets of […]
Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 – Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use
GBI Research has released its pharmaceutical research, “”Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use””, which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific […]
PharmaPoint: Atopic Dermatitis – Global Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – India Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – China Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – Japan Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – UK Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – Spain Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]
PharmaPoint: Atopic Dermatitis – Italy Drug Forecast and Market Analysis to 2022
Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for […]